TrialThe Journal of antimicrobial chemotherapy2014

Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure.

A Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.